$24.55
Value $3.0B
Privia HealthvsThermo Fisher Scientific
PRVA and TMO stock compared: price, dividend, valuation and results, from SEC filings.
+3.72%
$700.22
Value $260B
Privia Health (PRVA) has a market value of $3.0B and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, PRVA moved +1.4% and TMO +19.5%. The P/E is 87.4 for PRVA and 36.8 for TMO. Dividend yield: PRVA none, TMO 0.26%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
PRVA$3.0B
TMO$260B
TMO is 86 times PRVA
Revenue, 12 months
PRVA$2.4B
TMO$47.4B
TMO is 19 times PRVA
Net income, 12 months
PRVA$35M
TMO$7.1B
TMO is 204 times PRVA
Operating margin
PRVA2.1%
TMO17.9%
15.8 points apart
ROIC
PRVA4.2%
TMO8.2%
4.0 points apart
P/E
PRVA87.4
TMO36.8
PRVA is 2.4 times TMO
Dividend yield
PRVA0.0%
TMO0.3%
0.3 points apart
5-year return
PRVA-24.4%
TMO+11.8%
36.2 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
PRVA-24.4%
TMO+11.8%
| Period | PRVAWith dividends | TMOWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +1.4%Price +1.4% | +19.5%Price +19.1% |
| 3 years since November 13, 2023 | +15.3%+4.9% a yearPrice +15.3% | +58.8%+16.7% a yearPrice +57.3% |
| 5 years since November 12, 2021 | -24.4%-5.5% a yearPrice -24.4% | +11.8%+2.3% a yearPrice +10.2% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
PRVAPrivia HealthTMOThermo Fisher Scientific
Valuation
PRVATMO| Price | $24.55 | $700.22 |
|---|---|---|
| Market value | $3.0B | $260B |
| Enterprise value (EV) | $2.6B | $295B |
| P/E | 87.4 | 36.8 |
| P/E, 5-year median | – | 32.7 |
| P/B | 3.7 | 4.8 |
| EV/EBIT | 50.8 | 34.9 |
| Free cash flow yield | – | 2.9% |
Results and growth
PRVATMO| Revenue, 12 months | $2.4B | $47.4B |
|---|---|---|
| Net income, 12 months | $35M | $7.1B |
| Free cash flow, 12 months | – | $7.6B |
| Earnings per share, 12 months | $0.26 | $18.96 |
| Revenue growth, year on year | 22.3% | 3.9% |
| Revenue growth a year, past | +21.0%over 5 years | +6.7%over 5 years |
| EPS growth a year, past | -11.4%over 5 years | +2.1%over 5 years |
Margins and returns on capital
PRVATMO| Gross margin | – | – |
|---|---|---|
| Operating margin | 2.1% | 17.9% |
| Net margin | 1.4% | 14.9% |
| ROIC | 4.2% | 8.2% |
| ROE | 4.6% | 13.4% |
Balance sheet
PRVATMO| Cash | $446M | $6.1B |
|---|---|---|
| Total debt | $8.3M | $41.4B |
| Net debt / EBITDA | -7.3 | 3.7 |
| Interest cover | – | 5.5× |
Dividends and buybacks
PRVATMO| Dividend yield | – | 0.3% |
|---|---|---|
| Dividend per share, 12 months | – | $1.84 |
| Dividend growth a year, past | – | +14.3%over 5 years |
| Buyback yield | – | 1.2% |
| Shareholder yield | – | 1.4% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Privia Health or Thermo Fisher Scientific?
By market value, Thermo Fisher Scientific ($260B) is about 85.7 times Privia Health ($3.0B), at today's prices.
How did PRVA and TMO stock do over the last 5 years?
Since November 12, 2021, PRVA's price moved -24.4% and TMO's +10.2%. With dividends: PRVA -24.4% (-5.5% a year), TMO +11.8% (+2.3% a year). Past returns do not predict future ones.
Which pays the higher dividend, PRVA or TMO?
The dividend yield at today's price is none for Privia Health and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.
What is the P/E of PRVA and TMO?
At today's price, the P/E is 87.4 for PRVA and 36.8 for TMO. It is the share price over the last twelve months' earnings per share.
Which has the higher profit margins, Privia Health or Thermo Fisher Scientific?
Over the last twelve months, the net margin was 1.4% for Privia Health and 14.9% for Thermo Fisher Scientific, and the operating margin 2.1% and 17.9%. Revenue was $2.4B and $47.4B.
Which is the better investment, Privia Health or Thermo Fisher Scientific?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.